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A B S T R A C T
The aim of this study was to determine the prevalence of the genital mycoplasmas cervical colonization among the
pregnant women from the Eastern Croatia and to evaluate its correlation with the demographic and the behavioural risk
factors. Study was conducted from March 2010 to April 2011 at the Microbiology Department of the Institute of Public
Health for the Osijek-Baranja County. The study included 456 pregnant women in the first and the second trimester of
pregnancy. Demographic data and data on their possible risk behaviour during the lifetime were collected with the usage
of an anonymous questionnaire consisting of the 16 questions. The Mycoplasma Duo kit test was used to diagnose the
mycoplasma infections. Due to the fact that the results were generally similar for the women with U. urealyticum or M.
hominis and in order to dichotomize the analyses, 164 (36%) participants with U. urealyticum, M. hominis or both were
considered positive, whereas 292 (64%) participants without U. urealyticum or M. hominis were considered negative. A
higher genital mycoplasmas prevalence was statistically significantly associated with the younger group of the pregnant
women (16–29 y), 5 or more sexual partners during lifetime and the age on the first intercourse £16. The study has
showed that both the demographic and the behavioural risk factors were associated with the higher genital mycoplasmas
colonization in the observed population.
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Introduction
Genital mycoplasmas Mycoplasma hominis (M. homi-
nis) and Ureaplasma urealyticum (U. urealyticum) are of-
ten found in the genitourinary tract of the sexually active
women and can be a part of the normal flora as common
commensal inhabitants. U. urealyticum has been de-
tected in the lower genital tract of the 40 to 80% sexually
active women and is common in the vaginal flora of the
pregnant women. Genital mycoplasmas although consid-
ered to be of a low pathogenicity, may also play a role in
the many different infections and the multiple obstetri-
cal complications. U. urealyticum seems to be more viru-
lent and more associated with the vaginitis, cervicitis,
salpingitis, infertility, funisitis, chorioamnionitis, pre-
term premature rupture of the membranes, preterm de-
livery and postpartum endometritis than M. hominis1.
Spontaneous preterm labour and preterm birth is an im-
portant contributor to the perinatal mortality and mor-
bidity. On this track the cervical colonization could be
useful for predicting preterm birth because it is impossi-
ble to perform amniocentesis on every pregnant woman.
Some earlier studies found no relationship between the
Ureaplasma colonization and the premature birth, while
others claims that U. urealyticum is the microbe most
commonly found in the intra-amniotic infection and that
it significantly increases the risk of the preterm birth
and the preterm rupture of the membranes (PROM)2–7.
Different study population and some risk factors could
have masked the effect of U. urealyticum and may have
been reasons for the mentioned different results. Recent
study done by Abele-Horn showed that the high density
of the vaginal colonization with U. urealyticum is an in-
dependent risk factor for the clinical chorioamnionitis
and preterm delivery8. A joint effect of the vaginal U.
urealyticum and the bacterial vaginosis on the adverse
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pregnancy outcome was also described9. Ureaplasma
urealyticum include two different biovars. Biovar 1 in-
cludes 1, 3, 6 and the 14 serovars while the biovar 2 in-
cludes 2, 4, 5, 7–13 serovars. Recently, Kim at al. showed
that the difference between the biovars in the cervix did
not influence the occurrence of the preterm labor10. Intra-
amniotic infection with the genital mycoplasmas is more
intense than the intraamnionitic infection with the other
organisms with the preterm rupture of membranes11.
The intrauterine presence of the mentioned organisms
may results in the increase of the synthesis of prosta-
glandins, cytokines and metalloproteinases, and thus
leads to the preterm labour and delivery12. U. urealy-
ticum may be perinatally transmitted to the new-born
with the transmission rates and the prevalence increas-
ing inversely with the gestational age. Tracheal coloniza-
tion with U. urealyticum increases the risk from respira-
tory complications such as the development of the respi-
ratory distress syndrome, bronchopulmonary dysplasia
and chronic lung disease. Invasive infection occurs com-
monly in the very low birth weight infants and may in-
crease the risk for the severe intraventricular hemorrha-
ge6–8,12–16. Previous studies have shown that the diffe-
rent prevalence of U. urealyticum and M. hominis in the
pregnant women depends on the geographical areas. De-
spite the well-known possible consequences of the myco-
plasmatic infections in pregnancy, there has not been any
epidemiological report concerning the prevalence of the-
se infections among the pregnant woman in Croatia. The
aim of the present study was to determine the prevalence
of the cervical colonization by U. urealyticum and M.
hominis among the pregnant women from the Eastern
Croatia and to evaluate its correlation with the demo-
graphic and the behavioural risk factors.
Materials and Methods
Patients and specimens
This cross-sectional study was conducted from March
2010 to April 2011 and analysed at the Microbiology De-
partment of the Institution for the Public Health Osijek-
-Baranja County. The study population included 456
pregnant women (from 4000 pregnant women in the
Osijek-Baranja County) in the first and second trimester
of pregnancy. Prior to the enrolment in the study, each
women was informed on the objectives and the purpose
of the study. With the approval of the Ethics Committee
of Osijek University, Faculty of Medicine informed con-
sent for the participation in the study and the anony-
mous questionnaire were obtained from each pregnant
women. Anonymous questionnaire included demogra-
phic characteristics and the potential risk factors for the
cervical colonization with the analysed microorganisms.
Specimens were the cervical swabs for genital mycoplas-
mas. They were obtained during the routine prenatal ex-
amination at the primary health care gynaecologist of-
fices. After the collection, the cervical swab for U. urealy-
ticum and M. hominis was inserted into the Mycoplasma
Duo suspension medium (BIO RAD). After the inocula-
tion in the mentioned medium the specimen can be
stored for 48 hours at room temperature or 72 hours at
+2–8 °C.
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TABLE 1
ANONYMOUS QUESTIONNAIRE FOR PREGNANT WOMEN-STUDY SUBJECTS IN THE STUDY ABOUT GENITAL MYCOPLASMAS
COLONIZATION DURING PREGNANCY
Please circle or write your answer!
1. Place of residence: a) town b) village
2. The year of birth:
3. Marital status: a) married b) single c) divorced
4. Level of education: a) unfinished elementary school b) finished elementary school c) finished high school d) finished college
e) finished faculty
5. This is my first pregnancy during lifetime a) YES b) NO
6. Have you ever had habitual abortion? a) YES b) NO
7. Have you ever had preterm delivery? a) YES b) NO
8. Have you ever had extra uterine pregnancy? a) YES b) NO
9. Age of first intercourse:
10. During the sexual intercourse with new partners during lifetime I have always used condoms: a) YES b) NO
11. Number of sexual partners during lifetime : a) 1–4 b) 5 or more
12. Have you ever use public swimming pool? a) YES b) NO
13. Have you ever use public gym? a) YES b) NO
14. Have you ever use public sauna? a) YES b) NO
15. Have you ever, during lifetime had genital mycoplasmas infection (Ureaplasma Urealyticum, Mycoplasma hominis)? a) YES b) NO
16. Have you ever, during lifetime had another sexually transmitted disease? a) YES b) NO
Thank you very much for your cooperation!
Anonymous questionnaire
Study subjects were asked to fill-in an anonymous
questionnaire in order to identify the different demo-
graphic and the behavioural risk factors that may have
implied their exposure to genital mycoplasmas. There
were 16 questions, 14 of them of the closed type (with the
optional answers to be marked) and two of the open type
(the year of the birth and the age of the first intercourse).
Demographic data included the place of residence, age,
level of education and marital status. Data of their previ-
ous pregnancies included the questions about the parity,
previous habitual abortion, previous preterm delivery
and previous extra uterine pregnancy. Data on the sexual
preferences included the questions on the sexual activity
during the lifetime, age of the first intercourse, number
of sexual partners during the lifetime, regular condom
use during the sexual contacts with new partners and
lifetime history of the sexually transmitted diseases
(STDs). Data on their possible risk behaviour included
the public swimming pool, public gym and public sauna
use. The questionnaire used in the study is presented in
the Table 1.
Culture procedure
The Mycoplasma Duo kit (BIO RAD) was used to di-
agnose mycoplasma infections17. It enabled cultivation,
identification and indicative enumeration of U. urealy-
ticum and M. hominis. The combination of three antibi-
otics and an antifungal agent provided the selectivity, en-
suring that any contaminant flora in the specimen does
not affect the test. Identification of the urogenital myco-
plasmas was based on the specific metabolic properties of
each organism: the hydrolysis of urea by U. urealyticum
and the hydrolysis of arginine by M. hominis with the re-
lease of ammonia and the alkalisation of the medium.
The reaction is visualized by a change in the colour of the
pH indicator from yellow to red (phenol red). Yellow mi-
cro well suggested no mycoplasmas in the sample and red
micro well suggested presence of the mycoplasmas in the
sample. Results were first read after the incubation for
24 hours on 37 °C and provided the definitive result in
the high-titre specimens (³104 CCU/mL). A second read-
ing performed after 48 hours incubation on 37 °C was
needed to detect the strains present in the high titres
(³104 CCU/mL) witch were characterized by a slow meta-
bolic rate. A Mycoplasma Duo test allows differential ti-
tration of the two mycoplasma species which may have
both been present in the same specimen. The Myco-
plasma S.I.R. kit (BIO RAD) was used for the antibiotic
susceptibility testing.
Statistics
Descriptive statistics was used for the data processing
and analysed using the SPSS Statistical Package for the
Windows, version 13.0 (SPSS Inc., Chicago, IL, USA).
The c2- test and the Fisher exact test were used in order
to determine the differences in the distribution of the
qualitative variables. In all statistical analyses, two-sided
p-values of 0.05 and the lesser ones were considered sig-
nificant.
Results
A total of 456 pregnant women were analysed in the
present study. A positive cervical culture for U. urealy-
ticum or M. hominis or both was present in 164 (36 %) of
pregnant women. Of the women with the positive cervi-
cal culture for U. urealyticum and/or M. hominis,154
(93.9%) had U. urealyticum only, 2 (1.2%) had M. hominis
only and 8 (4.9%) had both U. urealyticum and M. ho-
minis (Table 2). Because the results were generally simi-
lar for women with U. urealyticum or M. hominis, the
analyses was dichotomised that 164 (36%) participants
with U. urealyticum, M. hominis or both were considered
positive, whereas 292 (64%) participants without U.
urealyticum or M. hominis were considered negative (Ta-
ble 3). Their data, obtained from each pregnant women
by an anonymous questionnaire are shown in the Table
4. There were no significant differences between the
women with the positive and the women with the nega-
tive cervical culture for U. urealyticum and/or M. homi-
nis regard to the basic characteristics like the age, place
of residence, marital status and level of education. Since
an age is an important determinant of the sexual beha-
viour18, the study subjects were divided into two age
groups: the younger group, aged 16–29 (N=266) and the
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TABLE 2
POSITIVE CERVICAL CULTURE OF U.UREALYTICUM AND/OR
M.HOMINIS COLONIZATION AMONG PREGNANT WOMEN FROM
THE EASTERN CROATIA
Positive cervical colonization N (%)
Solely U. urealyticum 154 (93.9)
Solely M. hominis 2 (1.2)
Both U. urealyticum and M. hominis 8 (4.9)
Total 164 (100)
TABLE 3
PREVALENCE OF U.UREALYTICUM AND/OR M.HOMINIS COLONIZATION AMONG PREGNANT WOMEN FROM THE EASTERN CROATIA
Cervical colonization Positive (%) Negative (%) Total (%)
Solely U. urealyticum 154 (33.7) 302 (66.3) 456 (100)
Solely M. hominis 2 (0.4) 454 (99.6) 456 (100)
Both U. urealyticum and M. hominis 8 (1.7) 448 (98.3) 456 (100)
Total 164 (36) 292 (64) 456 (100)
older group, aged 30–43 (n=190) years. Positive cervical
culture for U. urealyticum and/or M. hominis was re-
corded in 106/266 (39.8%) subjects from the younger
group and 58/190 (30.5%) subjects from the older group.
Significantly more frequent positive cervical culture for
U. urealyticum and/or M. hominis were in the younger
group (p= 0.04, c2=4.183). Higher number (five or more)
of sexual partners during lifetime and the age of the first
intercourse £16 were sexual risk behaviour connected
with the genital mycoplasmas positivity (p=0.01; c2=
5.622 and p=0.03; c2=4.945). History of the habitual
abortion (p=0.009; c2=6.786), preterm delivery and other
STDs (p=0.03; c2=4.406) were more frequent among the
women with the negative cervical culture than the wo-
men with the positive cervical culture for U. urealyticum
and/or M. hominis. Other possible risk factors include
the parity, extra uterine pregnancy, use of condom on
sexual contact with new partner, public swimming pool,
public gym and public sauna use have not provoked any
differences between the women. Considering the preva-
lence of the possible risk factors for the genital mycoplas-
mas infections in U. urealyticum and/or M. hominis posi-
tive and negative subjects, the younger group of pregnant
women (16–29 y), five or more sexual partners during
lifetime, the age on the first intercourse £16, no history
of habitual abortion and no history of other STDs were
more common in the pregnant women with the positive
cervical culture for U. urealyticum and/or M. hominis.
Discussion and Conclusion
There is no doubt that U. urealyticum and M. hominis
are associated with the adverse pregnancy outcomes. But
in reality, the mentioned organisms are rarely cultivated
routinely in the clinical practice and because of the low
awareness are often undiagnosed19. The role of the geni-
tal mycoplasmas in the ascending genital tract infection
is logical and the colonized pregnant women possess bac-
teria in their vaginal flora that are at least potentially ca-
pable of ascending through the cervix. It remains ob-
scure why they causes colonization in some pregnant
women and leads to the infection in the others. There
might be other associated factors which increase the ca-
pacity of the microorganism to invade the uterine cavity
including stress on the mother or fetus, the blood borne
infection of the placenta, the short cervix allowing the
vaginal flora to be close to the foetal membranes, the
over distension of the uterus and the altered vaginal
flora with the elevated concentrations of the proinflam-
matory microorganisms. Colonization density, virulence
variability and infection sensitivity of the host may play
a role in development of the infection20. In Croatia, the
data on the prevalence of U. urealyticum and M. hominis
colonization in the pregnant women are not reported.
There is no consensus on the monitoring of the pregnant
women with the colonization. Also, there are no system-
atic monitoring of the prevalence of the neonatal disease
including the prevalence of the neonatal infection caused
by U. urealyticum and M. hominis21. The present study
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TABLE 4
DEMOGRAPHIC AND BEHAVIOURAL RISK FACTORS FOR
GENITAL MYCOPLASMAS COLONIZATION AMONG PREGNANT
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that included that pregnant women from the Eastern
Croatia was the first study specifically investigated the
genital mycoplasmas prevalence in the population of the
Croatian pregnant women. A positive cervical culture of
U. urealyticum or M. hominis or both was present in
164/456 (36 %) of the pregnant women. Prevalence of U.
urealyticum and M. hominis colonization showed re-
gional variations from 11 to 63% and from 5 to 48%
(Czech Republic, Hungary, Belgium, Chile, Argentina,
Japan, Israel, South Africa). The mentioned values are
comparable to the Croatian samples despite the fact that
genital mycoplasmas colonization in the Croatian preg-
nant women was a little bit lower22–28. The problem of es-
tablishing a role of the genital mycoplasmas depends
partly on the laboratory diagnostics. Genital mycoplas-
mas presence was first based on culture but now molecu-
lar methods such as polymerase chain reaction (PCR)
and DNA hybridization are commonly used29,30. They are
rapid and reliable tests for the detection of these organ-
isms with the great specificity and have the ability to be
used in the quantitative mode. Due to their costs, there
are the differences in the technical expertise between the
laboratories. The limitation of the present study is the
fact that The Mycoplasma Duo kit (BIO RAD), which is
not molecular method, was used for the cultivation and
the detection of the genital mycoplasmas. Because of that
we probably have lower number of the positive subjects
in our study. Only the Czech Republic and Israel studies
had used the same diagnostic method, while others stud-
ies used molecular method (PCR) for a detection of the
genital mycoplasmas. In the present study, the higher
genital mycoplasmas colonization (106/266; 39.8%, p=
0.04, c2=4.183) was associated with the younger group of
pregnant women (16–29 y) which is in agreement with
the other report28. From the sexual risk behaviour, five
or more sexual partners during lifetime (26/164; 15.9%,
p=0.01, c2=5.622) and the age at the first intercourse
£16 (45/164; 27.4%, p=0.03, c2=4.945) were more com-
mon in the pregnant women with the positive cervical
culture for U. urealyticum and/or M. hominis. The men-
tioned findings confirm the fact that the number of sex-
ual partners during a lifetime and the duration of sexual
activity represent greater risk for STDs31,32. Overall
number of the extra uterine pregnancy (4/456; 0.8%),
genital mycoplasmas infections (66/456; 14.4%), and
other STDs (59/456; 13%) are very low for all study sub-
jects and because of that we have probably failed to suc-
ceed in our attempt to confirm the association between
genital mycoplasmas positivity and these potential risk
factors. History of the preterm deliveries (56/292; 19.1%)
and the habitual abortion (60/292; 20.5% and p=0.009,
c2=6.786) were more common in the pregnant women
with the negative cervical culture for U. urealyticum
and/or M. hominis than the women with the positive cer-
vical culture. In Croatia it is not mandatory to obtain the
cervical swabs in all pregnant women but there are rec-
ommendations to obtain the mentioned swabs and to
analyse them in the mentioned pregnant women who are
considered to have high-risk pregnancies33. In our study,
we showed that pregnant women who have no history of
spontaneous abortions and preterm delivery and accord-
ing to those criteria in Croatia they are not classified in
the group of women with the high-risk pregnancies ulti-
mately have a positive finding for genital mycoplasmas in
their cervical swabs. With our research we thus con-
firmed the findings of some authors who had discovered
that in the most pregnancies that are considered to be
the high-risk complications in fact do not develop, as op-
posed to the low-risk pregnancies in which the complica-
tions often develop resulting in a various adverse out-
comes34–36. Data obtained by the anonymous question-
naire showed that all the study subjects do not use the
public swimming pool (152/456; 33.3%), public gym (147/
456; 32.2%) and public sauna (66/456; 14.4%) often and
because of that the present study did not show the con-
nection between the genital mycoplasmas colonization
and some of the above mentioned behaviours. In conclu-
sion, the importance of the genital mycoplasmas in the
pregnancy requires further investigations. The group of
the pregnant women with genital mycoplasmas coloniza-
tion (36%) is far too large to be suitable for an interven-
tion strategy, because the administration of the antibiot-
ics could also cause more harm than benefit. Screening
for the genital mycoplasmas and the other risk factors
for the spontaneous preterm birth should allow a selec-
tion of women who may benefit from the prenatal treat-
ment. In the era characterized by the need for the most
cost-effective health-care on the one hand and at the
same time highly efficient and efficacious health care on
the other hand, the respective and comprehensive stud-
ies should be continued and extended in Croatia. We sug-
gest a study predicting the costs of the routine screenings
of the pregnant women and comparing them with the
current treatment the costs of the genital mycoplasmas
infections and their secondary consequences in Croatia.
The issues of the infectious diseases leading to the pre-
term birth and the other complications of pregnancy do
not end with delivery. The new-born may be born with
the infection and in this respect we should not forget the
potential severe sequels for the child. It is necessary for
the obstetricians, neonatal intesivists and public health
professionals to be involved in solving the issue because
the definitive conclusion on the development of the na-
tional strategy can only be made upon the large-scale and
comprehensive epidemiological studies, done by the in-
terdisciplinary teams of experts.
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U^ESTALOST I RIZI^NI ^IMBENICI CERVIKALNE KOLONIZACIJE GENITALNIM
MIKOPLAZMAMA TRUDNICA U ISTO^NOJ HRVATSKOJ
S A @ E T A K
Cilj ovoga istra`ivanja bio je utvrditi u~estalost i rizi~ne ~imbenike kolonizacije cerviksa genitalnim mikoplazmama
kod trudnica s podru~ja isto~ne Hrvatske, te procijeniti njezinu povezanost s demografskim osobinama i rizi~nim pona-
{anjima ispitanica. Studija je provedena u razdoblju od o`ujka 2010. godine do travnja 2011. godine u Zavodu za javno
zdravstvo Osje~ko-baranjske `upanije, Slu`ba za mikrobiologiju. U istra`ivanje je uklju~eno 456 trudnica u prvom i
drugom trimestru trudno}e. Demografski podatci o ispitanicama, te podatci o njihovom eventualnom rizi~nom pona-
{anju tijekom `ivota dobiveni su pomo}u anonimnog anketnog upitnika koji se sastojao od 16 pitanja. Za detekciju
genitalnih mikoplazmi kori{ten je Mycoplasma duo Kit test. Budu}i da su rezultati op}enito sli~ni za `ene s U. urea-
lyticum ili M. hominis kolonizacijom odlu~ili smo dihotomizirati na{e rezultate, tako da smo ispitanice s U. urealyticum,
M. hominis kolonizacijom ili oboje (164; 36%) smatrali pozitivnima, a ispitanice bez U. urealyticum ili M. hominis
kolonizacije (292; 64%) smo smatrali negativnima. Vi{a prevalencija je statisti~ki zna~ajno bila povezana s: mla|om
dobnom skupinom trudnica (16–29), s ve}im brojem (pet ili vi{e) spolnih partnera tijekom `ivota te s ranijim stupanjem
u spolne odnose (£16 godina prvi spolni odnos). Studija je pokazala da su demografske karakteristike i rizi~no
pona{anje ispitanica povezani s vi{om prevalencijom genitalnih mikoplazmi u promatranoj populaciji.
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